In early May 2026, Genpact reported first-quarter 2026 results with revenue of US$1.30 billion and net income of US$147.99 million, alongside ongoing share repurchases under its multi-year buyback program.
At the same time, Genpact expanded its alliance with Google Cloud to launch agentic AI finance tools for CFOs, underscoring a faster shift toward higher-value, AI-led services within its business mix.
We’ll now examine how the expanded Google Cloud AI alliance could reshape Genpact’s existing investment narrative around higher-margin digital solutions.
AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
Genpact Investment Narrative Recap
To own Genpact, you need to believe its pivot toward higher value, AI-led services can offset slower legacy BPO growth while preserving margins and cash returns. The Q1 2026 beat and ongoing buybacks support that narrative, but the market’s negative reaction to softer guidance keeps the biggest short term risk front and center: that demand softness or slower deal conversion makes it harder to hit revenue and earnings targets, even as AI investments ramp.
The expanded Google Cloud alliance is particularly relevant here, because it squarely targets Genpact’s main catalyst: growing Advanced Technology Solutions and recurring, non FTE revenue. By launching agentic AI tools for CFOs on Google Cloud’s Agent Marketplace, Genpact is deepening its presence in higher margin finance workflows, aiming to shift its mix further toward digital, AI-rich offerings that have been outgrowing the rest of the portfolio.
Yet despite this progress, investors should also be aware that…
Read the full narrative on Genpact (it’s free!)
Genpact’s narrative projects $6.3 billion revenue and $730.9 million earnings by 2029. This requires 7.6% yearly revenue growth and a $178.4 million earnings increase from $552.5 million today.
Uncover how Genpact’s forecasts yield a $47.73 fair value, a 38% upside to its current price.
Exploring Other Perspectives 
G 1-Year Stock Price Chart
The lowest ranked analysts take a more cautious view, assuming revenue of about US$6.4 billion and earnings near US$706 million by 2029, and the latest Google Cloud AI push could either support that conservative path or force a rethink of just how limited Genpact’s upside really is.
Explore 4 other fair value estimates on Genpact – why the stock might be worth over 3x more than the current price!
Form Your Own Verdict
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
A great starting point for your Genpact research is our analysis highlighting 5 key rewards that could impact your investment decision.
Our free Genpact research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Genpact’s overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Early movers are already taking notice. See the stocks they’re targeting before they’ve flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include G.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com